EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Inhibitory leukocyte immunoglobulin-like receptors, subfamily B (LILRBs) in human diseases: structure, roles, mechanisms, and clinical applications

Yuxiu Zhang, Yuanyuan Xu, Qihui Wu, Xiaodan Fu, Yimin Li, Anqi Li

Theranostics · 25.07.2025 · 15 (16) · 8222-8258

DOI: 10.7150/thno.116951 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Theranostics, erschienen am 25.07.2025. Verfasst von Yuxiu Zhang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China, 200025. Hauptthemen laut MEDLINE: Receptors, Immunologic, Neoplasms. Die Arbeit wurde bisher 8-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Leukocyte immunoglobulin-like receptors, subfamily B (LILRBs), are a class of critical immunosuppressive receptors that contribute to immune homeostasis by transmitting suppressive signals upon binding to ligands such as major histocompatibility complex class I molecules. They play key roles in modulating both innate and adaptive immune responses. This review summarizes the structural features, ligand interactions, signaling pathways, and expression regulation of LILRBs, and discusses their roles in immune cell function and disease progression, particularly in the tumor microenvironment. We also review current progress in the development of LILRB-targeted therapies for hematological malignancies and solid tumors and outline the challenges and future directions in translating these findings into clinical applications. By integrating recent advances, this review provides a framework for understanding the potential of LILRBs as therapeutic targets in cancer and immune-related disorders.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Receptors, ImmunologicNeoplasmsHumansAnimalsSignal TransductionTumor MicroenvironmentAdaptive ImmunityImmunity, Innate

Stichwörter der Autor:innen

hematological malignanciesimmune regulationimmunosuppressive receptorsimmunotherapysolid tumors

Substanzen

Receptors, Immunologic

Autor:innen und Institutionen

  • Department of Pathology, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China, 200025.
  • Department of Pathology, Zhongshan Hospital, Fudan University, Shanghai, China, 200032.
  • Department of Gynecology, Xiangya Hospital, Central South University, Changsha, China, 410008.
  • National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Changsha, China, 410008.
  • Department of Pathology, Xiangya Hospital, Central South University, Changsha, China, 410008.

Zitieren

APA

Zhang, Y., Xu, Y., Wu, Q., Fu, X., Li, Y., & Li, A. (2025). Inhibitory leukocyte immunoglobulin-like receptors, subfamily B (LILRBs) in human diseases: structure, roles, mechanisms, and clinical applications. Theranostics, 15(16), 8222-8258. https://doi.org/10.7150/thno.116951

Vancouver

Zhang Y, Xu Y, Wu Q, Fu X, Li Y, Li A. Inhibitory leukocyte immunoglobulin-like receptors, subfamily B (LILRBs) in human diseases: structure, roles, mechanisms, and clinical applications. Theranostics. 2025;15(16):8222-8258. doi:10.7150/thno.116951

BibTeX
@article{Zhang2025,
  author = {Zhang, Yuxiu and Xu, Yuanyuan and Wu, Qihui and Fu, Xiaodan and Li, Yimin and Li, Anqi},
  title = {Inhibitory leukocyte immunoglobulin-like receptors, subfamily B (LILRBs) in human diseases: structure, roles, mechanisms, and clinical applications},
  journal = {Theranostics},
  year = {2025},
  volume = {15},
  number = {16},
  pages = {8222--8258},
  doi = {10.7150/thno.116951}
}
Kostenlos starten →